Items tagged with Advocacy
World TB Day 2019: IT'S TIME for action! (post with simple image)
The World Health Organization releases advocacy and communications materials to support awareness building and promotion in the lead up to and on World TB Day.
TB CAB statement on safety of using bedaquiline and delamanid together (post with simple image)
Global TB CAB welcomes confirmation of safety of using bedaquiline and delamanid together, urges uptake.
TAG statement on FDA priority review of pretomanid (post with simple image)
Statement from Treatment Action Group on FDA priority peview of TB Alliance’s new anti-TB drug pretomanid.
UNAIDS reports mixed progress towards reaching the 2020 target of reducing TB deaths among people living with HIV by 75% (post with simple image)
Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action.
Building an Evidence Base to Advocate for TB Research (post with simple image)
TAG TB Project Co-Director Mike Frick discusses how public databases maintained by the NIH have been instrumental in supporting TAG's efforts to track global funding for TB research over time and hold governments and donors accountable to their TB research commitments.
TB CAB statement on M72/AS01E TB vaccine candidate development (post with simple image)
Statement by the Global TB Community Advisory Board to the High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate
TB LAM testing briefs (post with simple image)
Two important tools for activists to use with donors and national TB programs in advocating for increased scale-up of the inexpensive, urine TB LAM test - an essential diagnostic test for TB in people living with HIV.
Advocates raise serious concerns about errors in the WHO guidelines for the treatment of drug-resistant TB (post with simple image)
Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.
MSF: Johnson & Johnson should make TB drug available for all at $1/day (post with simple image)
MSF protests at J&J’s annual shareholders meeting to demand a say in how lifesaving TB drug developed with considerable joint efforts, including public funding and MSF operational research, will be made available and affordable.
Ad-hoc donations of bedaquiline threaten sustainable, affordable access for patients (post with simple image)
Advocates call on Indian Minister of Health to discontinue and phase out the drug donations of bedaquiline offered by Johnson & Johnson.
Page 73 of 74 · Total posts: 0←First 72 73 74 Last→